Modeling and Simulation - PK/PD Archives | Page 7 of 46

On-Demand Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Improve pediatric drug development with Certara’s Pediatric Practice, MIDD expertise for PIPs/PSPs, dose selection, regulatory…

CertaraNovember 10, 2025

Publication

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…

CertaraNovember 5, 2025

On-Demand Webinar

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…

CertaraNovember 3, 2025

Blog

Empowering the PK Community: Insights from the Phoenix® User Events

Explore insights from the Phoenix User Events in Europe, where experts shared innovations in automation,…

CertaraNovember 3, 2025

Blog

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…

CertaraOctober 24, 2025

On-Demand Webinar

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…

CertaraOctober 21, 2025

Blog

Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings

Discover how TFL Studio accelerates PK/PD reporting. Create audit-ready tables, figures, and listings faster with…

CertaraOctober 16, 2025

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraOctober 15, 2025

Live Events

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

– Scarman, Coventry, UK

CertaraOctober 14, 2025

Conference

ICAComP 2025

CertaraOctober 8, 2025

Modeling and Simulation – PK/PD

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

Empowering the PK Community: Insights from the Phoenix® User Events

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

ICAComP 2025

Newsletter sign up

Quick links

Solutions

Contact